Patent Invalidation in Ottawa.

A patent invalidation Ottawa defendant relies on has to reflect where the fights come from — and in Ottawa they come from telecoms and photonics. The city is the seat of the Federal Court of Canada and the home of the Canadian Intellectual Property Office (CIPO), and its Kanata North technology park — long nicknamed “Silicon Valley North” — concentrates the country’s optical-networking, semiconductor and wireless R&D. That mix drives standard-essential-patent and photonics disputes where the whole case turns on prior art. PerspireIP builds invalidity-grade searches for the accused parties and counsel who need to knock a Canadian patent out at the Federal Court or through CIPO re-examination.

Where a patent invalidation Ottawa case is actually heard

Canada splits validity and infringement between two court systems, and the distinction is decisive. The Federal Court of Canada has exclusive jurisdiction to impeach a patent — to declare it, or any of its claims, invalid or void with effect against the world. That in-rem power comes from section 60 of the Patent Act: an impeachment action can be started by the Attorney General or by any “interested person,” a low bar that a competitor or accused infringer clears easily. A win in Ottawa removes the patent from the register for everyone, not just the parties.

A provincial superior court — the Ontario Superior Court of Justice, for example — can hear a patent infringement action, but it cannot invalidate a patent in rem. If a provincial court accepts an invalidity defence, that finding binds only the parties to that lawsuit; the patent stays alive on CIPO’s register. This is why serious validity attacks are brought federally.

• Federal Court of Canada — exclusive impeachment jurisdiction under s.60; invalidity declared with in-rem effect; principal seat in Ottawa
• Federal Court of Appeal — hears appeals from Federal Court patent judgments
• Supreme Court of Canada — final appeal, with leave, and located in Ottawa
• Provincial superior courts — may try infringement, but invalidity binds the parties only (inter partes), never in rem

Whether the attack is a defensive counterclaim in an infringement suit or a standalone impeachment action, the outcome hinges on what was publicly available before the claim date. The prior art is the engine of the case.

CIPO re-examination: the lower-cost route to challenge a Canadian patent

Federal Court impeachment is not the only option. Under section 48.1 of the Patent Act, any person can ask CIPO to re-examine an issued claim by filing prior art — patents, published applications and printed publications — together with written submissions explaining its pertinency and how it reads on the claims. A request can be filed at any time before the patent expires, and it can be filed anonymously.

A re-examination board of three CIPO members then decides, within three months, whether the filing raises a substantial new question of patentability. If it does, the board re-examines the claims and can cancel, confirm or narrow them. It is far cheaper and faster than trial — but the trade-off is real: a third-party requester has no ongoing role after the initial filing, cannot lead evidence or cross-examine, and re-examination is confined to patent-and-publication prior art. It cannot run public-use, obviousness-over-common-general-knowledge or other fact-heavy grounds.

Because the requester’s one shot is the prior-art package itself, a re-examination lives or dies on the quality of the documents filed. And a re-examination board decision does not preclude a later court challenge, so the two routes can be sequenced. Choosing between Federal Court impeachment and CIPO re-examination — or combining them — is a strategy call the prior art should drive.

Silicon Valley North: why Ottawa’s patent fights are telecoms and photonics

Ottawa is not a generic capital. Its Kanata North technology park is the largest in Canada — more than 540 companies and roughly 24,000 employees — and it has carried the “Silicon Valley North” label for decades. Ericsson, Ciena, Nokia and BlackBerry QNX all run major operations there, much of it inherited from the Nortel and Bell-Northern Research lineage that seeded the cluster. Ciena absorbed Nortel’s optical assets; Nokia bases global optics and photonics work in the region.

The concentration is extraordinary: roughly 90% of Canada’s industrial telecommunications R&D happens in the Ottawa area, alongside the country’s deepest pool of compound-semiconductor and photonics talent and assets like the Canadian Photonics Fabrication Centre. Add the federal government-technology market — secure communications, defence and public-sector IT — and you have a patent landscape dominated by wireless, optical networking and chips.

That subject-matter shapes the disputes. Standard-essential patents on cellular and optical-transport standards, photonic-integrated-circuit claims and semiconductor process patents are the assertions that reach Ottawa counsel. These are exactly the claims where a well-dated reference — a standards contribution, a conference paper, an older datasheet — decides validity.

Where telecoms, photonics and semiconductor prior art lives

Electronics and photonics claims are anticipated in a literature that a patent-database-only search will miss. Much of the decisive art sits in standards archives and the engineering record, and its public-availability date has to be proved, not assumed. A credible invalidity search for an Ottawa telecoms or photonics patent reaches those sources directly.

• Standards-body contributions and meeting records — 3GPP, IEEE, ITU-T and OIF — where a technique is often first disclosed for standard-essential claims
• IEEE and OSA/Optica journals and conference proceedings (OFC, ECOC, ISSCC) for photonics and semiconductor art
• Datasheets, application notes and product manuals whose publication date can be evidenced
• Older and abandoned patent families, frequently argued as obviousness combinations under Canadian law
• Theses and technical reports from carrier and university labs, common in the Ottawa-Nortel research lineage

For a standard-essential patent the anticipating reference is often a working-group contribution filed years before grant, not a headline patent. We treat dating as evidence: for every reference we establish that it was genuinely public before the claim date the patent actually relies on, in a form a Federal Court judge or a CIPO re-examination board will accept.

Ottawa is the seat of CIPO and the Federal Court

Few cities put the patent office and the impeachment court in the same place. The Canadian Intellectual Property Office — the agency that grants Canadian patents and runs re-examination — is headquartered in the National Capital Region, and the Federal Court of Canada has its principal seat in Ottawa, as does the Federal Court of Appeal and the Supreme Court of Canada. The register you are trying to change and the court that can change it are both administered from the capital.

Proximity, though, confers no substantive advantage on a local address. The Federal Court is a national court: it sits and hears matters across Canada, and a patent asserted against an Ottawa company can be impeached by an interested person based anywhere. What decides a Canadian validity fight is not where counsel is based but the strength and dating of the prior art — a standards contribution, an older patent family, a dated datasheet — married to the right ground of invalidity under the Patent Act.

That is the discipline behind a patent invalidation Ottawa strategy: use the federal forum’s in-rem power, or CIPO’s re-examination route, and back it with evidence built to survive scrutiny.

How Canadian validity law differs: no US-style IPR, and the promise doctrine’s rise and fall

Counsel used to US practice should not assume Canada mirrors it. There is no US-style inter partes review in Canada — no PTAB, no adversarial administrative trial with discovery and cross-examination. CIPO re-examination is the closest analogue, but it is document-only and gives the requester no continuing role. For a full, contested validity attack with live witnesses and expert evidence, the Federal Court is the forum.

Canadian utility law also has its own history. For years the “promise doctrine” let courts measure utility against every promise a patentee made in the disclosure and invalidate the patent if any went unmet — a rule that hit pharmaceutical patents hard. In AstraZeneca Canada Inc. v. Apotex Inc., 2017 SCC 36, the Supreme Court of Canada abolished it, holding that a mere scintilla of utility, demonstrated or soundly predicted by the filing date, satisfies the Patent Act. Utility is now a weaker attack, which pushes more weight onto novelty and obviousness — and onto the prior art that proves them.

Other differences matter too: Canada’s obviousness test follows the Sanofi four-part framework, and claim date, not filing date, governs what counts as prior art for novelty. A search built for a US IPR does not automatically transfer; it has to be re-scoped to Canadian grounds and dates.

How PerspireIP builds the invalidity case

Every engagement follows the same disciplined path. We map the asserted claims element by element, fix the claim date that actually governs each one, and search against that date rather than the grant date on the cover. For telecoms, photonics and semiconductor subject-matter we run patent and deep non-patent-literature searching in parallel — standards archives, IEEE and Optica records, conference proceedings and datasheets — then build claim charts a Federal Court judge or a CIPO re-examination board can follow.

• Claim charting mapped to Canadian novelty and to obviousness under the Sanofi framework
• Deep retrieval across 3GPP, IEEE, ITU-T and OIF standards, journals, conference proceedings and older patent families
• Public-availability dating for every reference, evidenced for standards contributions, papers and product literature
• Prior art sized to your route — a Federal Court impeachment or infringement counterclaim, or a s.48.1 CIPO re-examination package
• A written invalidity analysis and reference packages ready for court or the re-examination board

We work alongside your Canadian litigation counsel and agents as a specialist search partner, deliver to Federal Court and CIPO deadlines, and keep every engagement confidential. Whether you are a Kanata technology company facing an assertion, a new entrant clearing a path, or litigation counsel preparing an impeachment action, we scale to fit — a single search, a multi-patent campaign or ongoing support. Send us the Canadian patent number and your key dates, and we will scope a patent invalidation Ottawa project within one business day.

IP Landscape & Resources in Ottawa

Key intellectual-property authorities and venues relevant to Ottawa:

• Canadian Intellectual Property Office (CIPO) — the office that grants Canadian patents and administers s.48.1 re-examination of issued claims
• Federal Court of Canada — the court with exclusive jurisdiction to impeach a patent and declare claims invalid in rem, with its principal seat in Ottawa
• Patent Act (RSC 1985, c. P-4) — the governing statute; s.60 sets out impeachment and s.48.1 sets out re-examination

Request a Patent Invalidation Search in Ottawa

Explore related PerspireIP services: Patent Invalidation · Prior Art Litigation Search · Patent Infringement Analysis.

Frequently Asked Questions